These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 704600)

  • 1. [Interactions of reserve antitubercular agents in combined administration].
    Korotaev GA; Kozulitsyna TM
    Probl Tuberk; 1978 Sep; (9):56-60. PubMed ID: 704600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
    Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
    Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
    [No Abstract]   [Full Text] [Related]  

  • 5. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 8. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV
    Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
    [No Abstract]   [Full Text] [Related]  

  • 11. [New and future drugs in pulmonary tuberculosis].
    Grosset JH; Truffot-Pernot C; Lecoeur H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
    Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F
    Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
    Merkel S; Fischer P; Weinecke W
    Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
    Kozulitsyna TI; Petrov IV
    Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.